EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Technologies and Future Directions in Interorgan Crosstalk Cardiometabolic Research

Hosung Bae iD, Christy M Nguyen, Jorge Ruiz-Orera, Nicholas L Mills iD, Michael P Snyder iD, Cholsoon Jang iD, Svati H Shah iD, Norbert Hübner, Marcus Seldin iD

Circulation Research · 23.05.2025 · 136 (11) · 1494-1506

DOI: 10.1161/circresaha.125.325515 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 23.05.2025. Verfasst von Hosung Bae und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry and Center of Epigenetics and Metabolism, School of Medicine, University of California Irvine School of Medicine (…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Biomedical Research. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The heart does not work in isolation, with cardiac health and disease occurring through complex interactions between the heart with multiple organs. Furthermore, the integration of organ-specific lipid metabolism, blood pressure, insulin sensitivity, and inflammation involves a complex network of signaling pathways between many organs. Dysregulation in these communications is now recognized as a key contributor to many manifestations of cardiovascular disease. Mechanistic characterization of specific molecules mediating interorgan signaling has been pivotal in advancing our understanding of cardiovascular disease. The discovery of insulin, glucagon, and other hormones in the early 20th century illustrated the importance of communication between organs in maintaining physiological homeostasis. For example, elegant studies evaluating insulin signaling and its role in regulating glucose metabolism have shed light on its broader impact on cardiovascular health, hypertension, atherosclerosis, and other cardiovascular disease risks. Recent technological advances have revolutionized our understanding of interorgan signaling. Global approaches such as proteomics and metabolomics applications to blood have enabled the simultaneous profiling of thousands of circulating factors, revealing previously unknown signaling molecules and pathways. These large-scale studies have identified biomarkers linked to early stages of heart disease and offered new therapeutic targets. By understanding how specific cells in the heart interact with cells in other organs, such as the kidney or liver, researchers can identify key pathways that, when disrupted, lead to cardiovascular pathology. The ability to capture a more holistic view of the cardiovascular system positions interorgan signaling at the forefront of cardiovascular research. As we continue to refine our tools for mapping these complex networks, the insights gained hold the potential to not only improve early diagnosis but also to develop more targeted and effective treatments for cardiovascular disease. In this review, we discuss current approaches used to enhance our understanding of organ crosstalk with a specific emphasis on cardiac and cardiovascular physiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesBiomedical ResearchHumansAnimalsSignal TransductionMetabolomicsProteomics

Stichwörter der Autor:innen

blood pressurecardiovascular diseasescell communicationendocrine systemheart diseaseshypertension

Autor:innen und Institutionen

  • Department of Biological Chemistry and Center of Epigenetics and Metabolism, School of Medicine, University of California Irvine School of Medicine (H.B., C.M.N., C.J., M.S.).
  • Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany (J.R.-O., N.H.).
  • BHF Centre for Cardiovascular Science (N.L.M.), The University of Edinburgh, United Kingdom.
  • Usher Institute (N.L.M.), The University of Edinburgh, United Kingdom.
  • Department of Genetics, Stanford University School of Medicine, CA (M.P.S.).
  • Duke Center for Precision Health (S.H.S.), Duke University School of Medicine, Durham, NC.

ORCID-Profile: Hosung Bae, Nicholas L Mills, Michael P Snyder, Cholsoon Jang, Svati H Shah, Marcus Seldin

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Bae, H., Nguyen, C. M., Ruiz-Orera, J., Mills, N. L., Snyder, M. P., Jang, C., Shah, S. H., Hübner, N., & Seldin, M. (2025). Emerging Technologies and Future Directions in Interorgan Crosstalk Cardiometabolic Research. Circulation Research, 136(11), 1494-1506. https://doi.org/10.1161/circresaha.125.325515

Vancouver

Bae H, Nguyen CM, Ruiz-Orera J, Mills NL, Snyder MP, Jang C, et al. Emerging Technologies and Future Directions in Interorgan Crosstalk Cardiometabolic Research. Circulation Research. 2025;136(11):1494-1506. doi:10.1161/circresaha.125.325515

BibTeX
@article{Bae2025,
  author = {Bae, Hosung and Nguyen, Christy M and Ruiz-Orera, Jorge and Mills, Nicholas L and Snyder, Michael P and Jang, Cholsoon and Shah, Svati H and Hübner, Norbert and Seldin, Marcus},
  title = {Emerging Technologies and Future Directions in Interorgan Crosstalk Cardiometabolic Research},
  journal = {Circulation Research},
  year = {2025},
  volume = {136},
  number = {11},
  pages = {1494--1506},
  doi = {10.1161/circresaha.125.325515}
}
Kostenlos starten →